Disclaimer and Trademarks

Investigational status

DuraRad is investigational and not approved for clinical use. Except for the DuraRad Evaluation Kit, a research-use-only prototype offered under its own Evaluation Kit Agreement, nothing on this site is an offer to sell, or a solicitation to buy, any product, and no statement here should be read as a claim of safety, efficacy, or regulatory clearance.

No offer of securities

Nothing on this site is an offer to sell, or a solicitation of an offer to buy, any security. Any securities offering by FabUTech LLC is private, is made only under an available exemption from registration, and is made only through offering documents delivered directly to the recipient. Information on this site about the company, its technology, its market, and its plans is provided as factual business information and not as an offering communication.

Forward-looking statements

This site describes technology under active development. Statements about development status, regulatory strategy, intellectual property, and future plans are forward-looking and subject to change. They reflect current intent and are not guarantees of outcome, timing, or approval.

No performance claims

Descriptions of DuraRad on this site address the problem it targets and the approach it takes. Illustrative and modeled figures, and the measured cold-chemistry clearance rate, are shown publicly with their status noted; they are not, and should not be interpreted as, validated performance results. Full validation datasets and the results of the scheduled radioactive study are shared separately, under appropriate confidentiality terms, as part of the DuraRad data package.

Trademarks

DuraRad™ is a trademark of FabUTech LLC. Other names referenced on this site may be trademarks of their respective owners and are used for identification only; their use does not imply any affiliation or endorsement.

Contact

Questions about this notice can be directed to [email protected].